Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L. Kampman MT, et al. Among authors: steffensen lh. Mult Scler. 2012 Aug;18(8):1144-51. doi: 10.1177/1352458511434607. Epub 2012 Feb 21. Mult Scler. 2012. PMID: 22354743 Clinical Trial.
Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.
Steffensen LH, Mellgren SI, Kampman MT. Steffensen LH, et al. J Neurol. 2010 Mar;257(3):410-8. doi: 10.1007/s00415-009-5337-6. Epub 2009 Oct 1. J Neurol. 2010. PMID: 19795152
The role of vitamin D in multiple sclerosis.
Kampman MT, Steffensen LH. Kampman MT, et al. Among authors: steffensen lh. J Photochem Photobiol B. 2010 Nov 3;101(2):137-41. doi: 10.1016/j.jphotobiol.2010.04.003. Epub 2010 Apr 21. J Photochem Photobiol B. 2010. PMID: 20471852 Review.
Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial.
Steffensen LH, Jørgensen L, Straume B, Mellgren SI, Kampman MT. Steffensen LH, et al. J Neurol. 2011 Sep;258(9):1624-31. doi: 10.1007/s00415-011-5980-6. Epub 2011 Mar 13. J Neurol. 2011. PMID: 21400196 Free PMC article. Clinical Trial.
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
Steffensen LH, Brustad M, Kampman MT. Steffensen LH, et al. J Neurol. 2013 Jan;260(1):182-8. doi: 10.1007/s00415-012-6611-6. Epub 2012 Aug 1. J Neurol. 2013. PMID: 22850935 Clinical Trial.
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T. Røsjø E, et al. Among authors: steffensen lh. J Neurol. 2015 Dec;262(12):2713-21. doi: 10.1007/s00415-015-7902-5. Epub 2015 Oct 1. J Neurol. 2015. PMID: 26429571 Clinical Trial.
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.
Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T. Røsjø E, et al. Among authors: steffensen lh. Mult Scler. 2017 Mar;23(3):395-402. doi: 10.1177/1352458516654310. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 27325604
High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT. Holmøy T, et al. Among authors: steffensen lh. BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0. BMC Neurol. 2017. PMID: 28376767 Free PMC article. Clinical Trial.
Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
Holmøy T, Røsjø E, Zetterberg H, Blennow K, Lindstrøm JC, Steffensen LH, Kampman MT. Holmøy T, et al. Among authors: steffensen lh. Acta Neurol Scand. 2019 Feb;139(2):172-176. doi: 10.1111/ane.13037. Epub 2018 Nov 12. Acta Neurol Scand. 2019. PMID: 30317548 Clinical Trial.
Thrombolysis in anterior spinal artery syndrome.
Müller KI, Steffensen LH, Johnsen SH. Müller KI, et al. Among authors: steffensen lh. BMJ Case Rep. 2012 Sep 7;2012:bcr2012006862. doi: 10.1136/bcr-2012-006862. BMJ Case Rep. 2012. PMID: 22962400 Free PMC article.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback